Hikma’s Genestin Takes A Strategic Approach To BD
Newly-Appointed Executive Sets Out Growth Strategy For Generics Business
Business development must be treated as a “strategic tool,” with partnerships and acquisitions selected based on how they fit into the company’s bigger picture, Hikma’s newly-appointed vice-president of business development for generics Patrick Genestin tells Generics Bulletin in an exclusive interview.
